Stock listing

NASDAQ:CRGX CARGO Therapeutics, Inc. Stock

Follow CARGO Therapeutics, Inc. into a list and get an email when it puts out news.

Last close · NASDAQ:CRGX

$4.47 USD

Close on Aug 20, 2025 · No longer trades

Nov 9, 2023 to last close -70.2% · weekly closes, Nov 9, 2023 – Aug 20, 2025
Lowest – highest close
$3.39 – $32.23 USDSince Nov 9, 2023 · lowest Jan 30, 2025 · highest Mar 7, 2024

Delisted NASDAQ:CRGX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CRGX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

CARGO Therapeutics, Inc. on 6ix

Decks
2 decks · latest Feb 24, 2025

Decks

DeckKindSlidesDate
Investor Presentation (February 2025)Investor deck45 slidesFeb 24, 2025
J.P. Morgan Healthcare Conference 2024Conference17 slidesJan 8, 2024

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Lubner
Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Arcellx Inc (Director · Since at least Feb 3, 2022); Dyne Therapeutics, Inc. (Board Member · Since at least Jul 31, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); POINT Biopharma Global Inc (Director · Jul 7, 2020 – Dec 26, 2023 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Ra Pharmaceuticals Inc (Executive VP and CFO · Oct 25, 2016 – Apr 2, 2020 · Past); Tetraphase Pharmaceuticals Inc (SVP and CFO · Mar 19, 2013 – Aug 14, 2015 · Past)
Director · Since at least Nov 9, 2023
John Orwin
Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); AnaptysBio, Inc. (Board Chairman of First Tracks Bio Former CEO of Relypsa · Since at least Sep 15, 2023); Travere Therapeutics, Inc. (Director · Since at least Mar 23, 2017); Atreca Inc (PRESIDENT & CEO, Director · Jun 19, 2019 – Apr 11, 2024 · Past); Seagen Inc (Director · Jan 10, 2014 – Dec 14, 2023 · Past); Relypsa Inc (President & CEO, Director · Nov 14, 2013 – Sep 1, 2016 · Past); Affymax Inc (Director · Apr 12, 2010 – Jun 27, 2013 · Past); NeurogesX Inc (Director · Nov 19, 2009 – Jun 7, 2012 · Past)
Director · Since at least Nov 9, 2023
Jane Pritchett Henderson
Other companies: Apogee Therapeutics, Inc. (Chief Financial Officer · Since at least Jul 13, 2023); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Invivyd, Inc. (Chief Financial Officer · Aug 5, 2021 – Jan 30, 2022 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – May 3, 2021 · Past); IVERIC bio Inc (Director · Jan 13, 2018 – Jul 11, 2023 · Past); Voyager Therapeutics, Inc. (Sr. V.P. & CFO, Corp. Dev. · Jan 1, 2017 – Mar 22, 2018 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past)
Director · Since at least Jun 3, 2024
Kapil Dhingra
Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Black Diamond Therapeutics, Inc. (Director · Since at least Jan 19, 2021); Replimune Group, Inc. (Director · Since at least Jul 19, 2018); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – Apr 16, 2021 · Past)
Director · Since at least Apr 15, 2024
Reid Huber
Other companies: Rapport Therapeutics, Inc. (Partner, Third Rock Ventures · Since at least Jun 6, 2024); Tango Therapeutics, Inc. (Director · Aug 10, 2021 – Jun 6, 2023 · Past); Bellicum Pharmaceuticals Inc (Director · Dec 17, 2014 – Jan 3, 2023 · Past); Incyte Corporation (EVP, Chief Scientific Officer · Apr 27, 2014 – Jul 16, 2018 · Past)
Director · Since at least Nov 9, 2023
Abraham Bassan
Other companies: Rani Therapeutics Holdings, Inc. (Director · Since at least Oct 23, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); LENZ Therapeutics, Inc. (Director · Jun 24, 2021 – Jul 19, 2023 · Past)
Director · Since at least Nov 9, 2023
Gina Chapman
Other companies: Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Sep 1, 2023)
President & CEO, Director · Nov 9, 2023 – Mar 14, 2025 · Past
Krishnan Viswanadhan
Other companies: Agios Pharmaceuticals, Inc. (Chief Strategy and Operations Officer · Since at least Mar 5, 2025)
Director · Since at least Nov 9, 2023
Anup RadhakrishnanSee Remarks · Since at least Nov 9, 2023
Ginna LaportChief Medical Officer · Nov 9, 2023 – Mar 14, 2025 · Past
All 11 people
PersonSeat
Shishir GadamChief Technical Officer · Nov 9, 2023 – Mar 14, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about CARGO Therapeutics, Inc.